Ivan Correia

Title: Discovering the Innovations of Ivan Correia

Introduction

Ivan Correia, a notable inventor based in Winchester, MA, has made significant contributions to the field of biopharmaceuticals through his innovative inventions. With a record of five patents, he focuses on enhancing the efficacy and safety of therapeutic proteins and antibodies. His groundbreaking work, coupled with diverse collaborations, has propelled advancements in protein production and purification.

Latest Patents

Ivan's latest patents showcase his expertise in protein glycosylation and antibody purification. One of his significant inventions is titled "Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosaccharides." This invention addresses the intricacies of protein production by introducing methods and compositions that effectively modulate the glycosylation of proteins expressed in host cells.

Another notable patent is centered around "Viral inactivation during purification of antibodies." This patent details innovative methods for isolating and purifying antibodies while mitigating viral contamination during the purification process. The approach highlights the importance of an acidification step followed by multiple chromatography techniques, enhancing the safety and quality of antibody therapies.

Career Highlights

Throughout his career, Ivan has held pivotal roles at esteemed organizations such as AbbVie Inc. and Brandeis University. His experience in these entities has fortified his knowledge and allowed him to contribute significantly to biopharmaceutical research and development. His work has not only advanced scientific understanding but has also led to practical applications in medicine.

Collaborations

Ivan Correia has collaborated with prominent peers in the industry, including Patrick Hossler and Orrie Friedman. These interactions have undoubtedly enriched his research endeavors, leading to innovative solutions in protein therapeutics. Collaborative efforts often inspire new ideas and foster the development of cutting-edge technologies in the field.

Conclusion

In conclusion, Ivan Correia exemplifies the spirit of innovation within the realm of biopharmaceuticals. His patents on glycosylation modulation and viral inactivation techniques underscore his commitment to enhancing therapeutic processes. As he continues to collaborate with industry professionals, Ivan's contributions are poised to have a lasting impact on the future of medical treatments.